By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Xbrane Biopharma 

Banvaktsvägen 22

Solna    171 48  Sweden
Phone: 46-0-763-093-777 Fax: n/a


SEARCH JOBS

Xbrane is a biopharmaceutical company specialized in high demand biosimilars and long acting injectables. The segment has a high entry barrier, driven by high production complexity and the need of specific Know-How. Xbrane currently possess its own expertise within production of complex generics with slow release formulation and unique technologies for producing proteins efficiently.

YEAR FOUNDED:

2008

LEADERSHIP:

CEO: Martin Åmark

CTO: David Vikström

COO: Siavash Bashiri

PRODUCTS:

All Products

FOLLOW XBRANE BIOPHARMA:



Key Statistics


Email: info@xbrane.com
Ownership: Private

Web Site: Xbrane Biopharma
Employees:
Symbol: 
 









Company News
Xbrane Biopharma Confirms Order Of Spherotide To Value Of SEK 8.5 Million And More Than 10,000 Doses Sold 9/11/2017 12:30:01 PM
Xbrane Biopharma Releases Interim Report For The Period April - June 2017 8/31/2017 11:20:48 AM
Xbrane Biopharma: Spherotide Granted Market Authorization In Iran 7/24/2017 11:33:51 AM
Complementary Information On Xbrane Biopharma's (Publ) Long-Term Share Savings Program For Employees 7/7/2017 10:43:17 AM
Xbrane Biopharma Announces A Directed New Share Issue Of SEK 20 Million 5/24/2017 12:14:05 PM
Minutes From Xbrane Biopharma's (Publ) Annual General Meeting 5/22/2017 8:07:39 AM
Xbrane Biopharma Releases Interim Report For The Period January - March 2017 5/18/2017 11:05:17 AM
Xbrane Biopharma Recruits CFO And Head Of Investor Relations 5/4/2017 11:32:24 AM
Xbrane Biopharma Reports Positive In-Vivo Efficacy Data On Spherotide 4/11/2017 10:20:28 AM
//-->